Sanaria Inc.

Related records

Trials (43)

• A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses
• A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI
• Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso
• Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso
• Chemoprotective Activity of MMV390048 in PfSPZ Challenge Model
• Clinical Trial of the PfSPZ Vaccine
• Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults
• Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis
• Controlled Human Malaria Infection by Intradermal Injection of Plasmodium Falciparum Sporozoites in Tanzanian Adults
• Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)
• Controlled Human Malaria Infection Transmission Model - Phase A
• Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults
• Dose Escalation PfSPZ-CVac
• Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults
• Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ Challenge
• Experimental Human Malaria Infection by PfSPZ
• Experimental PfSPZ Vaccine in Adults Without Malaria
• Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults
• Malaria CVD 36000; Gates INV090205
• Optimisation of Controlled Human Malaria Infection Using Sporozoites Administered by Needle and Syringe